期刊文献+

药物性肝损伤临床特点分析及疗效观察

A clinical analysis and treatment of the drug- induced liver injur
下载PDF
导出
摘要 目的探讨药物性肝病的临床特点及治疗方法。方法对解放军第102医院药物性肝损害206例患者的临床资料进行回顾性分析。结果引起肝损害的药物种类繁多,以抗生素(包括抗结核药物)为最多,占40.7%,其次为抗肿瘤药,占15.5%;临床以肝细胞型多见,占49.5%,胆汁淤积型占29.6%,混合型占20.9%;主要临床表现有纳差、乏力、黄疸、上腹部不适、皮疹、发热。实验室检查ALT升高206例(100%);ALP升高108例(52.4%);总胆红素升高54例(26.2%)。临床治愈165例,好转32例,自动出院7例,死亡2例。结论引起药物性肝损害的药物种类很多,应及早发现及时治疗。 Objective To analysis the clinical characteristics and the treatment of drug- induced liver injury. Methods 206 patients with DILD admitted to our hospital from 2000 to 2008 were reviewed retrospectively. Results A variety of drugs were involved in causing liver disease. The common offending agents were antimicrobial agents (40.7%), and antineoplastic ( 15.5 % ) ;49.5 % was classified as hepatocellular type, 29.6% as cholestatic type, and 20.9 % as mixed type. The main clinical manifestations were fatigue, jaundice, anorexia, epigastrium uncomfortable, rash, fever.The laboratory tests of liver functions showed increased levels of ALT( 100% ), ALP(52.4% ) and TD(26.2% ). The patients were recowered in 165 patients, improved in 32 patients, and died in 2 patients. Gonelusiorl A variety of drugs can induce liver disease, we should discover the immediate and cure early.
机构地区 解放军第
出处 《常州实用医学》 2010年第5期281-283,共3页 CHANGZHOU PRACTICAL MEDICINE
关键词 药物性肝损害 临床特点 治疗 回顾性研究 Drug - induced liver disease Clinical feature Treatment Etrospecfive study
  • 相关文献

参考文献7

  • 1药物性肝损害病死率位居全球第五[J].肝博士,2006(5):68-69. 被引量:17
  • 2许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 3叶维法.临床肝胆病学[M].天津科学技术出版社,2002.723-724.
  • 4Benichou C. Criteria of drug - induced liver disorders. Report of an international eonsonsus meeting[J] .J Hepatol, 1990, 11 : 272 - 276.
  • 5LEE W. Drag-induced hepatotoxieity[J].New Engl J Med, 2003,349(5) :474 - 485.
  • 6Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkofia K, Garcia- Ruiz E, Garcia- Munoz B, Gonzalez- Grande R, Hzarro A, Duran JA,Jimenez M, Rodrigo L, Romero- Gomez M, Navarro JM, Hanas R, Costa J, Borras A, Soler A, Salmeron J, Martin-Vivaldi R. Druginduced hver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10 - year period[J].Gastroenterology, 2005, 129: 512 - 521.
  • 7Meier Y, Cavallaro M, Roos M, Pauli- Magnus C, Folkem G, Meier PJ, Fattinger K. Incidence of drug induced liver injury in medical inpatients[J]. Eur J CAin Pharmacof,2005,61:135 - 143.

二级参考文献16

  • 1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
  • 2Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130.
  • 3Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247.
  • 4Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217.
  • 5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276
  • 6Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294.
  • 7Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243.
  • 8Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197.
  • 9Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med, 2006, 354:731-739.
  • 10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol, 2000, 33:949-952.

共引文献361

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部